Our Executive Director, Lauren Leiman, will participate in an expert panel discussion titled “Multi-Cancer Early Detection: Innovations and Real-World Evidence” at PMWC 2025 in Silicon Valley, California, on February 6, 2025. Moderated by Peter Bach of Delfi Diagnostics, the panel will feature esteemed leaders including Eric Klein, MD (Distinguished Scientist, Grail), Joshua Cohen, MD, PhD (Co-founder and Chief Innovation Officer, Haystack Oncology), Lauren Leiman (Executive Director, BLOODPAC), and Tomasz Beer, MD (VP and CMO, Exact Sciences).